FullHope Biomedical Co (ROCO:7773) Asset Turnover: 0.04 (As of Dec. 2025)


ROCO:7773 FullHope Biomedical Co Ltd ROCO:7773
14 GF Score
Price NT$27.65
! 1 Warning Sign
View Full Analysis

What is FullHope Biomedical Co Asset Turnover?

FullHope Biomedical Co ROCO:7773 14 Asset Turnover is 0.04 as of Dec. 2025. GuruFocus rates ROCO:7773 with a GF Score™ of 14/100. The stock has 1 warning sign investors should review.

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. FullHope Biomedical Co's Revenue for the six months ended in Dec. 2025 was NT$25.55 Mil. FullHope Biomedical Co's Total Assets for the quarter that ended in Dec. 2025 was NT$579.65 Mil. Therefore, FullHope Biomedical Co's Asset Turnover for the quarter that ended in Dec. 2025 was 0.04.

Asset Turnover is linked to ROE % through Du Pont Formula. FullHope Biomedical Co's annualized ROE % for the quarter that ended in Dec. 2025 was -6.37%. It is also linked to ROA % through Du Pont Formula. FullHope Biomedical Co's annualized ROA % for the quarter that ended in Dec. 2025 was -6.14%.

FullHope Biomedical Co  (ROCO:7773) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

FullHope Biomedical Co's annulized ROE % for the quarter that ended in Dec. 2025 is

ROE %**(Q: Dec. 2025 )
=Net Income/Total Stockholders Equity
=-35.606/558.7415
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-35.606 / 51.09)*(51.09 / 579.652)*(579.652/ 558.7415)
=Net Margin %*Asset Turnover*Equity Multiplier
=-69.69 %*0.0881*1.0374
=ROA %*Equity Multiplier
=-6.14 %*1.0374
=-6.37 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

FullHope Biomedical Co's annulized ROA % for the quarter that ended in Dec. 2025 is

ROA %(Q: Dec. 2025 )
=Net Income/Total Assets
=-35.606/579.652
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-35.606 / 51.09)*(51.09 / 579.652)
=Net Margin %*Asset Turnover
=-69.69 %*0.0881
=-6.14 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.

FullHope Biomedical Co Asset Turnover Related Terms

FullHope Biomedical Co Asset Turnover Historical Data

* Premium members only.

The historical data trend for FullHope Biomedical Co's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

FullHope Biomedical Co Asset Turnover Chart

FullHope Biomedical Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Asset Turnover
0.00 0.14 0.07 0.03 0.07

FullHope Biomedical Co Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Asset Turnover Get a 7-Day Free Trial 0.02 0.01 0.02 0.03 0.04

ROCO:7773 vs VRTX, REGN, ALNY: Asset Turnover Comparison

For the Biotechnology subindustry, FullHope Biomedical Co's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

FullHope Biomedical Co Asset Turnover vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, FullHope Biomedical Co's Asset Turnover distribution charts can be found below:

* The bar in red indicates where FullHope Biomedical Co's Asset Turnover falls into.


ROCO:7773
14GF Score
FullHope Biomedical Co Ltd ROCO:7773
Asset Turnover is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

FullHope Biomedical Co Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

FullHope Biomedical Co's Asset Turnover for the fiscal year that ended in Dec. 2025 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2025 )/( (Total Assets (A: Dec. 2024 )+Total Assets (A: Dec. 2025 ))/ count )
=43.6/( (610.908+571.447)/ 2 )
=43.6/591.1775
=0.07

FullHope Biomedical Co's Asset Turnover for the quarter that ended in Dec. 2025 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=25.545/( (587.857+571.447)/ 2 )
=25.545/579.652
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.

Frequently Asked Questions Learn more about Asset Turnover →
What does a Asset Turnover of 0.04 mean?
FullHope Biomedical Co (ROCO:7773) has a Asset Turnover of 0.04 as of Dec. 2025. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on FullHope Biomedical Co and its competitors.
Is FullHope Biomedical Co's Asset Turnover too high?
FullHope Biomedical Co's current Asset Turnover is 0.04. Overall, FullHope Biomedical Co has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does FullHope Biomedical Co's Asset Turnover compare to VRTX and REGN?
FullHope Biomedical Co's Asset Turnover of 0.04 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Asset Turnover for a Biotechnology company?
A good Asset Turnover depends on the Biotechnology industry context. However, Asset Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Asset Turnover mean?
A high Asset Turnover can signal that a stock is expensive relative to its fundamentals. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on FullHope Biomedical Co and its competitors. FullHope Biomedical Co's current Asset Turnover is 0.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is FullHope Biomedical Co stock overvalued right now?
FullHope Biomedical Co (ROCO:7773) has a current Asset Turnover of 0.04. The current Asset Turnover is 0.04. FullHope Biomedical Co's overall GF Score™ is 14/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Asset Turnover calculated?
Asset Turnover is calculated from a company's financial statements. For FullHope Biomedical Co (ROCO:7773), the current Asset Turnover is 0.04 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

FullHope Biomedical Co Business Description

Address Lane 609, Sector. 5, Chongxin Road, 10th Floor, No. 10, Sanchong District, New Taipei City, TWN
FullHope Biomedical Co Ltd focuses on immune system-related services and innovative R&D. It establishes cell-based immunotherapies for cancers and autoimmune disorders. Its services are, Immunoprofiling, Circulating Tumor Cells Testing, Regulation of Cell Therapy, Contracting Immune Cell Manufacturing, Immune Cell Bank, Contract Research Organization, and Endotoxin and Mycoplasma Detection Service.
14GF Score

Get the complete analysis for ROCO:7773

Asset Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$27.65
Price